Abstract:Three copper(ii) coordination compounds have been prepared from three different 2,2':6',2''-terpyridine-based ligands, which have been selected to investigate the potential role of supramolecular interactions on the DNA-interacting and cytotoxicity properties of the corresponding metal complexes. Hence, the ligands 4'-((naphthalen-2-yl)methoxy)-2,2':6',2''-terpyridine () and 4'-((1H-benzo[d]imidazol-2-yl)methoxy)-2,2':6',2''-terpyridine () have been synthesized from commercially-available 4'-chloro-2,2':6',2''… Show more
“…[13] Some years ago, we have described three copperterpyridine nitrato complexes with interesting cytotoxic properties. [14] In this previous study, the effect of supramolecular interactions on the biological properties was investigated, and the complex [Cu(naphtpy)(NO3)(H2O)](NO3)(MeOH) (where naphtpy stands for 4'-((naphthalen-2-yl)methoxy)-2,2′:6′,2′′terpyridine; Figure 1) exhibited notable cell toxicity behavior against several cancer cell lines. [14] In the present study, the ligand naphtpy was used to prepare copper(II) complexes with CuCl2 and Cu(ClO4)2 as the metal sources (instead of Cu(NO3)2).…”
Five copper complexes supported by terpyridine ligands were prepared and characterized, viz. 4) and [Cu(Cltpy)2](ClO4)2 ( 5); (where Naphtpy stands for 4'-((naphthalen-2-yl)methoxy)-2,2′:6′,2′′-terpyridine and Cltpy for 4′-chloro-2,2′:6′,2′′-terpyridine). Their DNA-interaction abilities were investigated, and their cytotoxic behaviors were examined with three cells lines, namely with human ovarian carcinoma cells (A2780) and its derived cisplatin-resistant line (A2780cis), and human cervix adenocarcinoma cells (HeLa). All compounds show good cytotoxic properties (especially after 72 h incubation). Remarkably, two compounds, i.e. 4 and 5, are almost inactive after 24 h (particularly 4), but are highly active after 72 h, with IC50 values in the low micromolar to submicromolar range. Compounds 1 and 2 induce necrosis, whereas late apoptosis is observed with 3−5, 4 exhibiting a behaviour close to that of cisplatin.
Results and Discussion
Preparation of the copper complexesReaction of Naphtpy with 1.5 equiv. of CuCl2•2H2O in methanol at 40 ºC produces the mixed-valence Cu I Cu II compound [a]
“…[13] Some years ago, we have described three copperterpyridine nitrato complexes with interesting cytotoxic properties. [14] In this previous study, the effect of supramolecular interactions on the biological properties was investigated, and the complex [Cu(naphtpy)(NO3)(H2O)](NO3)(MeOH) (where naphtpy stands for 4'-((naphthalen-2-yl)methoxy)-2,2′:6′,2′′terpyridine; Figure 1) exhibited notable cell toxicity behavior against several cancer cell lines. [14] In the present study, the ligand naphtpy was used to prepare copper(II) complexes with CuCl2 and Cu(ClO4)2 as the metal sources (instead of Cu(NO3)2).…”
Five copper complexes supported by terpyridine ligands were prepared and characterized, viz. 4) and [Cu(Cltpy)2](ClO4)2 ( 5); (where Naphtpy stands for 4'-((naphthalen-2-yl)methoxy)-2,2′:6′,2′′-terpyridine and Cltpy for 4′-chloro-2,2′:6′,2′′-terpyridine). Their DNA-interaction abilities were investigated, and their cytotoxic behaviors were examined with three cells lines, namely with human ovarian carcinoma cells (A2780) and its derived cisplatin-resistant line (A2780cis), and human cervix adenocarcinoma cells (HeLa). All compounds show good cytotoxic properties (especially after 72 h incubation). Remarkably, two compounds, i.e. 4 and 5, are almost inactive after 24 h (particularly 4), but are highly active after 72 h, with IC50 values in the low micromolar to submicromolar range. Compounds 1 and 2 induce necrosis, whereas late apoptosis is observed with 3−5, 4 exhibiting a behaviour close to that of cisplatin.
Results and Discussion
Preparation of the copper complexesReaction of Naphtpy with 1.5 equiv. of CuCl2•2H2O in methanol at 40 ºC produces the mixed-valence Cu I Cu II compound [a]
“…We found no indication here suggesting that the trans ruthenium complexes [1] + -[4] 2+ would form adducts with two or more oligonucleotides. Other interactions responsible for the binding of metallodrugs to DNA involve hydrogen bonding with especially the phoshphate backbone, 3,48,49 or pi-pi stacking interactions with the base pairs. [50][51][52] However, these interactions dramatically depend on the supramolecular assembly of nucleic acids (double-strands vs. single-strands, G-quadruplexes vs. 3-way junctions, etc.…”
Three new trans-ruthenium(ii) complexes coordinated to tetrapyridyl ligands, namely [Ru(bapbpy)(dmso)Cl]Cl ([2]Cl), [Ru(bapbpy)(Hmte)](PF) ([3](PF)), and [Ru(biqbpy)(Hmte)](PF) ([4](PF)), were prepared as analogues of [Ru(biqbpy)(dmso)Cl]Cl ([1]Cl), a recently described photoactivated chemotherapy agent. The new complexes were characterized, and their crystal structures showed the distorted coordination octahedron typical of this family of complexes. Their photoreactivity in solution was analyzed by spectrophotometry and mass spectrometry, which showed that the sulfur ligand was substituted upon blue light irradiation. The binding of the ruthenium complexes to a reference single-stranded oligonucleotide (s(CTACGGTTTCAC)) was explored both in the dark and under light irradiation by gel electrophoresis and high-resolution mass spectrometry. While adduct formation in the dark was negligible for the four complexes, light irradiation led to the formation of adducts with one or two ruthenium centers per oligonucleotide. The absence of interactions in the dark and the presence of complex-oligonucleotide adducts demonstrate that visible light controls the interaction of these ruthenium complexes with nucleic acids.
“…To a solution of 3-formyl-6methylchromone (0.188 g, 1 mmol) in methanol (10 ml) was added 8-aminoquinoline slowly (0.144 g, 1 mmol) dissolved in methanol (7 ml). The ligand appears immediately as a yellow colored precipitate; the mixture was stirred for 3 h at 60 C. (1). To a hot methanolic solution of ligand L (0.314 g, 1 mmol), was added Cu(NO 3 ) 2 -$3H 2 O (0.241 g, 1 mmol) drop-wise, a brown colored precipitate appeared.…”
Section: Synthesis Of Ligand (L)mentioning
confidence: 99%
“…Cisplatin obstructs DNA through binding to guanine bases is known, inducing kinks in the biomolecule, which leads to cell death. 1 Nevertheless, systemic side effects of cisplatin remain a challenge to overcome and result in new design strategies for developing efficacious antitumor drugs based on metals other than platinum. Next to ruthenium, copper complexes are regarded as the most promising alternatives for classical cisplatin-type drugs.…”
Synthesis and structural characterization of the novel copper complex, DFT based vibrational analysis, DNA binding studies. In vitro cytotoxicity against A549 cancer cell lines and estimation of GSH, ROS, LPO levels, have been reported.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.